Trypanosoma cruzi infection imparts a regulatory program in dendritic cells and T cells via galectin-1-dependent mechanisms

Journal of Immunology

Volumn 195, Issue 7, 2015, Pages 3311-3324

  Poncini, Carolina V ^a   Ilarregui, Juan M ^b,c   Batalla, Estela I ^a   Engels, Steef ^c   Cerliani, Juan P ^b   Cucher, Marcela A ^a   Van Kooyk, Yvette ^c   González Cappa, Stella M ^a   Rabinovich, Gabriel A ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GALECTIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; GAMMA INTERFERON; IDO1 PROTEIN, MOUSE; IL10 PROTEIN, MOUSE; INDOLEAMINE 2,3 DIOXYGENASE; PDCD1LG2 PROTEIN, MOUSE; PROGRAMMED DEATH 1 LIGAND 2;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CHAGAS DISEASE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; GLYCOSYLATION; HOMEOSTASIS; IMMUNOBLOTTING; IMMUNOGENICITY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C3H MOUSE; CYTOLOGY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPH NODE; METABOLISM; MORTALITY; PARASITE LOAD; PARASITOLOGY; REGULATORY T LYMPHOCYTE; TRYPANOSOMA CRUZI;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; DENDRITIC CELLS; GALECTIN 1; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPH NODES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, KNOCKOUT; PARASITE LOAD; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1; TRYPANOSOMA CRUZI;

EID: 84942436387     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403019     Document Type: Article

References (65)

1. World Health Organization. 2010. Chagas disease: control and elimination. Available at: http://apps.who.int/gb/ebwha/pdf-files/WHA63/A63-17-en.pdf.
2. Marin-Neto, J. A., E. Cunha-Neto, B. C. Maciel, and M. V. Simões. 2007. Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109-1123.
3. Abrahamsohn, I. A. 1998. Cytokines in innate and acquired immunity to Trypanosoma cruzi infection. Braz. J. Med. Biol. Res. 31: 117-121.
4. da Matta Guedes, P. M., F. R. Gutierrez, F. L. Maia, C. M. Milanezi, G. K. Silva, W. R. Pavanelli, and J. S. Silva. 2010. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl. Trop. Dis. 4: e604.
5. Tarleton, R. L., M. J. Grusby, M. Postan, and L. H. Glimcher. 1996. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8: 13-22.
6. Martin, D. L., D. B. Weatherly, S. A. Laucella, M. A. Cabinian, M. T. Crim, S. Sullivan, M. Heiges, S. H. Craven, C. S. Rosenberg, M. H. Collins, et al. 2006. CD8+ T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2: e77.
7. Rosenberg, C. S., D. L. Martin, and R. L. Tarleton. 2010. CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J. Immunol. 185: 560-568.
8. Teixeira, M. M., R. T. Gazzinelli, and J. S. Silva. 2002. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 18: 262-265.
9. DosReis, G. A. 2011. Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease. Braz. J. Med. Biol. Res. 44: 84-90.
10. Van Overtvelt, L., M. Andrieu, V. Verhasselt, F. Connan, J. Choppin, V. Vercruysse, M. Goldman, A. Hosmalin, and B. Vray. 2002. Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8+ T lymphocytes. Int. Immunol. 14: 1135-1144.
11. Planelles, L., M. C. Thomas, C. Marañón, M. Morell, and M. C. López. 2003. Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice. Clin. Exp. Immunol. 131: 41-47.
12. Alba Soto, C. D., G. A. Mirkin, M. E. Solana, and S. M. González Cappa. 2003. Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner. Infect. Immun. 71: 1194-1199.
13. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
14. Hammer, G. E., and A. Ma. 2013. Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu. Rev. Immunol. 31: 743-791.
15. Van Overtvelt, L., N. Vanderheyde, V. Verhasselt, J. Ismaili, L. De Vos, M. Goldman, F. Willems, and B. Vray. 1999. Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect. Immun. 67: 4033-4040.
16. Poncini, C. V., C. D. Alba Soto, E. Batalla, M. E. Solana, and S. M. González Cappa. 2008. Trypanosoma cruzi induces regulatory dendritic cells in vitro. Infect. Immun. 76: 2633-2641.
17. Poncini, C. V., G. Giménez, C. A. Pontillo, C. D. Alba-Soto, E. L. de Isola, I. Piazzón, and S. M. Cappa. 2010. Central role of extracellular signal-regulated kinase and Toll-like receptor 4 in IL-10 production in regulatory dendritic cells induced by Trypanosoma cruzi. Mol. Immunol. 47: 1981-1988.
18. van Kooyk, Y., and G. A. Rabinovich. 2008. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 9: 593-601.
19. Rabinovich, G. A., and M. A. Toscano. 2009. Turning "sweet" on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 9: 338-352.
20. Toscano, M. A., G. A. Bianco, J. M. Ilarregui, D. O. Croci, J. Correale, J. D. Hernandez, N. W. Zwirner, F. Poirier, E. M. Riley, L. G. Baum, and G. A. Rabinovich. 2007. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 8: 825-834.
21. Toscano, M. A., A. G. Commodaro, J. M. Ilarregui, G. A. Bianco, A. Liberman, H. M. Serra, J. Hirabayashi, L. V. Rizzo, and G. A. Rabinovich. 2006. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J. Immunol. 176: 6323-6332.
22. Levroney, E. L., H. C. Aguilar, J. A. Fulcher, L. Kohatsu, K. E. Pace, M. Pang, K. B. Gurney, L. G. Baum, and B. Lee. 2005. Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines. J. Immunol. 175: 413-420.
23. Ouellet, M., S. Mercier, I. Pelletier, S. Bounou, J. Roy, J. Hirabayashi, S. Sato, and M. J. Tremblay. 2005. Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J. Immunol. 174: 4120-4126.
24. Rabinovich, G. A., and D. O. Croci. 2012. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 36: 322-335.
25. Ilarregui, J. M., D. O. Croci, G. A. Bianco, M. A. Toscano, M. Salatino, M. E. Vermeulen, J. R. Geffner, and G. A. Rabinovich. 2009. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 10: 981-991.
26. Vasta, G. R. 2009. Roles of galectins in infection. Nat. Rev. Microbiol. 7: 424-438.
27. Baum, L. G., O. B. Garner, K. Schaefer, and B. Lee. 2014. Microbe-host interactions are positively and negatively regulated by galectin-glycan interactions. Front. Immunol. 5: 284.
28. Pelletier, I., and S. Sato. 2002. Specific recognition and cleavage of galectin-3 by Leishmania major through species-specific polygalactose epitope. J. Biol. Chem. 277: 17663-17670.
29. Kohatsu, L., D. K. Hsu, A. G. Jegalian, F. T. Liu, and L. G. Baum. 2006. Galectin-3 induces death of Candida species expressing specific b-1,2-linked mannans. J. Immunol. 177: 4718-4726.
30. Stowell, S. R., C. M. Arthur, M. Dias-Baruffi, L. C. Rodrigues, J. P. Gourdine, J. Heimburg-Molinaro, T. Ju, R. J. Molinaro, C. Rivera-Marrero, B. Xia, et al. 2010. Innate immune lectins kill bacteria expressing blood group antigen. Nat. Med. 16: 295-301.
31. Garner, O. B., H. C. Aguilar, J. A. Fulcher, E. L. Levroney, R. Harrison, L. Wright, L. R. Robinson, V. Aspericueta, M. Panico, S. M. Haslam, et al. 2010. Endothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation. PLoS Pathog. 6: e1000993.
32. Toledo, K. A., M. L. Fermino, Cdel. C. Andrade, T. B. Riul, R. T. Alves, V. D. Muller, R. R. Russo, S. R. Stowell, R. D. Cummings, V. H. Aquino, and M. Dias-Baruffi. 2014. Galectin-1 exerts inhibitory effects during DENV-1 infection. PLoS One 9: e112474.
33. Kleshchenko, Y. Y., T. N. Moody, V. A. Furtak, J. Ochieng, M. F. Lima, and F. Villalta. 2004. Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary artery smooth muscle cells. Infect. Immun. 72: 6717-6721.
34. Okumura, C. Y., L. G. Baum, and P. J. Johnson. 2008. Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis. Cell. Microbiol. 10: 2078-2090.
35. Zuñiga, E., G. A. Rabinovich, M. M. Iglesias, and A. Gruppi. 2001. Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis. J. Leukoc. Biol. 70: 73-79.
36. Zúñiga, E., A. Gruppi, J. Hirabayashi, K. I. Kasai, and G. A. Rabinovich. 2001. Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival. Infect. Immun. 69: 6804-6812.
37. Vray, B., I. Camby, V. Vercruysse, T. Mijatovic, N. V. Bovin, P. Ricciardi-Castagnoli, H. Kaltner, I. Salmon, H. J. Gabius, and R. Kiss. 2004. Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. Glycobiology 14: 647-657.
38. Ferrer, M. F., C. A. Pascuale, R. M. Gomez, and M. S. Leguizamón. 2014. DTU I isolates of Trypanosoma cruzi induce upregulation of galectin-3 in murine myocarditis and fibrosis. Parasitology 141: 849-858.
39. Pineda, M. A., L. Corvo, M. Soto, M. Fresno, and P. Bonay. 2015. Interactions of human galectins with Trypanosoma cruzi: binding profile correlate with genetic clustering of lineages. Glycobiology 25: 197-210.
40. González Cappa, S. M., A. T. Bijovsky, H. Freilij, L. Muller, and A. M. Katzin. 1981. [Isolation of a Trypanosoma cruzi strain of predominantly slender form in Argentina]. Medicina (B. Aires) 41: 119-120.
41. Zingales, B., S. G. Andrade, M. R. Briones, D. A. Campbell, E. Chiari, O. Fernandes, F. Guhl, E. Lages-Silva, A. M. Macedo, C. R. Machado, et al; Second Satellite Meeting. 2009. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem. Inst. Oswaldo Cruz 104: 1051-1054.
42. Solana, M. E., C. D. Alba Soto, M. C. Fernández, C. V. Poncini, M. Postan, and S. M. González Cappa. 2009. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection. Parasitology 136: 627-639.
43. Garín, M. I., C. C. Chu, D. Golshayan, E. Cernuda-Morollón, R. Wait, and R. I. Lechler. 2007. Galectin-1: a key effector of regulation mediated by CD4+ CD25+ T cells. Blood 109: 2058-2065.
44. Cedeno-Laurent, F., M. Opperman, S. R. Barthel, V. K. Kuchroo, and C. J. Dimitroff. 2012. Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J. Immunol. 188: 3127-3137.
45. Goñi, O., P. Alcaide, and M. Fresno. 2002. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1+)CD11b+ immature myeloid suppressor cells. Int. Immunol. 14: 1125-1134.
46. Knubel, C. P., F. F. Martínez, R. E. Fretes, C. Díaz Lujan, M. G. Theumer, L. Cervi, and C. C. Motrán. 2010. Indoleamine 2,3-dioxigenase (IDO) is critical for host resistance against Trypanosoma cruzi. FASEB J. 24: 2689-2701.
47. Arocena, A. R., L. I. Onofrio, A. V. Pellegrini, A. E. Carrera Silva, A. Paroli, R. C. Cano, M. P. Aoki, and S. Gea. 2014. Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection. Eur. J. Immunol. 44: 184-194.
48. Sanoja, C., S. Carbajosa, M. Fresno, and N. Gironès. 2013. Analysis of the dynamics of infiltrating CD4+ T cell subsets in the heart during experimental Trypanosoma cruzi infection. PLoS One 8: e65820.
49. da Costa, T. A., M. V. Silva, M. T. Mendes, T. M. Carvalho-Costa, L. R. Batista, E. Lages-Silva, V. Rodrigues, C. J. Oliveira, and L. E. Ramirez. 2014. Immunomodulation by Trypanosoma cruzi: toward understanding the association of dendritic cells with infecting TcI and TcII populations. J. Immunol. Res. 2014: 962047.
50. Giordanengo, L., S. Gea, G. Barbieri, and G. A. Rabinovich. 2001. Antigalectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease. Clin. Exp. Immunol. 124: 266-273.
51. Roffe, E., A. G. Rothfuchs, H. C. Santiago, A. P. Marino, F. L. Ribeiro-Gomes, M. Eckhaus, L. R. Antonelli, and P. M. Murphy. 2012. IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. J. Immunol. 188: 649-660.
52. Randolph, G. J., J. Ochando, and S. Partida-Sánchez. 2008. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 26: 293-316.
53. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779.
54. Belkaid, Y., and K. Tarbell. 2009. Regulatory T cells in the control of hostmicroorganism interactions. Annu. Rev. Immunol. 27: 551-589.
55. Montagnoli, C., A. Bacci, S. Bozza, R. Gaziano, P. Mosci, A. H. Sharpe, and L. Romani. 2002. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169: 6298-6308.
56. Belkaid, Y., C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
57. Amante, F. H., A. C. Stanley, L. M. Randall, Y. Zhou, A. Haque, K. McSweeney, A. P. Waters, C. J. Janse, M. F. Good, G. R. Hill, and C. R. Engwerda. 2007. A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am. J. Pathol. 171: 548-559.
58. Kotner, J., and R. Tarleton. 2007. Endogenous CD4+ CD25+ regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect. Immun. 75: 861-869.
59. Sales, P. A., Jr., D. Golgher, R. V. Oliveira, V. Vieira, R. M. Arantes, J. Lannes-Vieira, and R. T. Gazzinelli. 2008. The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi. Microbes Infect. 10: 680-688.
60. Mariano, F. S., F. R. Gutierrez, W. R. Pavanelli, C. M. Milanezi, K. A. Cavassani, A. P. Moreira, B. R. Ferreira, F. Q. Cunha, C. R. Cardoso, and J. S. Silva. 2008. The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect. 10: 825-833.
61. Monteiro, A. C., V. Schmitz, E. Svensjo, R. T. Gazzinelli, I. C. Almeida, A. Todorov, L. B. de Arruda, A. C. Torrecilhas, J. B. Pesquero, A. Morrot, et al. 2006. Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. J. Immunol. 177: 6325-6335.
62. Monteiro, A. C., V. Schmitz, A. Morrot, L. B. de Arruda, F. Nagajyothi, A. Granato, J. B. Pesquero, W. Müller-Esterl, H. B. Tanowitz, and J. Scharfstein. 2007. Bradykinin B2 receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses. PLoS Pathog. 3: e185.
63. Campetella, O., J. Martínez, and J. J. Cazzulo. 1990. A major cysteine proteinase is developmentally regulated in Trypanosoma cruzi. FEMS Microbiol. Lett. 55: 145-149.
64. Risso, M. G., G. B. Garbarino, E. Mocetti, O. Campetella, S. M. Gonzalez Cappa, C. A. Buscaglia, and M. S. Leguizamon. 2004. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. J. Infect. Dis. 189: 2250-2259.
65. Soares, R. P., A. C. Torrecilhas, R. R. Assis, M. N. Rocha, F. A. Moura e Castro, G. F. Freitas, S. M. Murta, S. L. Santos, A. F. Marques, I. C. Almeida, and A. J. Romanha. 2012. Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of a-galactosyl residues. Am. J. Trop. Med. Hyg. 87: 87-96.